IRWD
IRWD
US46333X1081
Ironwood Pharmaceuticals, Inc.
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 296.151.000 351.410.000
15.7%
Cost of Revenue -- --
--
Gross Profit -- --
--
177.392.000 255.693.000
30.6%
Operating Income 118.759.000 95.717.000
24.1%
Pretax Income 70.025.000 65.198.000
7.4%
Net Income Common Stockholders 24.017.000 880.000
2629.2%
-- --
--
-- --
--
ende